Alzamend Neuro Unveils Promising Data on AL001 from Phase II 'Lithium in Brain' Clinical Trial Alzamend Neuro has reported encouraging results from its Phase II trial of AL001, indicating effective lithium delivery in the brain, which could transform treatment for various mental health disorders.

Alzamend Neuro Unveils Promising Data on AL001 from Phase II 'Lithium in Brain' Clinical Trial #United_States #Massachusetts #Lithium #AL001 #Alzamend